Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 4
2003 4
2004 2
2005 4
2006 1
2007 5
2008 7
2009 4
2010 4
2011 6
2012 4
2013 11
2014 17
2015 12
2016 6
2017 9
2018 6
2019 7
2020 9
2021 6
2022 8
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Results by year

Filters applied: . Clear all
Page 1
Functional Signature of LRP4 Antibodies in Myasthenia Gravis.
Chuquisana O, Stascheit F, Keller CW, Pučić-Baković M, Patenaude AM, Lauc G, Tzartos S, Wiendl H, Willcox N, Meisel A, Lünemann JD. Chuquisana O, et al. Among authors: tzartos s. Neurol Neuroimmunol Neuroinflamm. 2024 May;11(3):e200220. doi: 10.1212/NXI.0000000000200220. Epub 2024 Mar 20. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38507656 Free PMC article.
PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders.
Topaloudi A, Jain P, Martinez MB, Bryant JK, Reynolds G, Zagoriti Z, Lagoumintzis G, Zamba-Papanicolaou E, Tzartos J, Poulas K, Kleopa KA, Tzartos S, Georgitsi M, Drineas P, Paschou P. Topaloudi A, et al. Among authors: tzartos s. Front Immunol. 2023 Sep 21;14:1147573. doi: 10.3389/fimmu.2023.1147573. eCollection 2023. Front Immunol. 2023. PMID: 37809097 Free PMC article.
Immunotherapies in MuSK-positive Myasthenia Gravis; an IgG4 antibody-mediated disease.
Vakrakou AG, Karachaliou E, Chroni E, Zouvelou V, Tzanetakos D, Salakou S, Papadopoulou M, Tzartos S, Voumvourakis K, Kilidireas C, Giannopoulos S, Tsivgoulis G, Tzartos J. Vakrakou AG, et al. Among authors: tzartos s. Front Immunol. 2023 Jul 26;14:1212757. doi: 10.3389/fimmu.2023.1212757. eCollection 2023. Front Immunol. 2023. PMID: 37564637 Free PMC article. Review.
Autoimmunity to neuronal nicotinic acetylcholine receptors.
Pechlivanidou M, Ninou E, Karagiorgou K, Tsantila A, Mantegazza R, Francesca A, Furlan R, Dudeck L, Steiner J, Tzartos J, Tzartos S. Pechlivanidou M, et al. Among authors: tzartos s. Pharmacol Res. 2023 Jun;192:106790. doi: 10.1016/j.phrs.2023.106790. Epub 2023 May 9. Pharmacol Res. 2023. PMID: 37164280 Free article. Review.
A miR-124-mediated post-transcriptional mechanism controlling the cell fate switch of astrocytes to induced neurons.
Papadimitriou E, Koutsoudaki PN, Thanou I, Karagkouni D, Karamitros T, Chroni-Tzartou D, Gaitanou M, Gkemisis C, Margariti M, Xingi E, Tzartos SJ, Hatzigeorgiou AG, Thomaidou D. Papadimitriou E, et al. Among authors: tzartos sj. Stem Cell Reports. 2023 Apr 11;18(4):915-935. doi: 10.1016/j.stemcr.2023.02.009. Epub 2023 Mar 23. Stem Cell Reports. 2023. PMID: 36963393 Free PMC article.
Immunological and Structural Characterization of Titin Main Immunogenic Region; I110 Domain Is the Target of Titin Antibodies in Myasthenia Gravis.
Stergiou C, Williams R, Fleming JR, Zouvelou V, Ninou E, Andreetta F, Rinaldi E, Simoncini O, Mantegazza R, Bogomolovas J, Tzartos J, Labeit S, Mayans O, Tzartos S. Stergiou C, et al. Among authors: tzartos s. Biomedicines. 2023 Feb 3;11(2):449. doi: 10.3390/biomedicines11020449. Biomedicines. 2023. PMID: 36830985 Free PMC article.
126 results